This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Founded in 1994 and headquartered in Denver, CO, DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services.
Can Nutrisystem (NTRI) Surprise Investors in Q4 Earnings?
by Zacks Equity Research
Nutrisystem Inc. (NTRI) is scheduled to release fourth-quarter 2016 results on Feb 27.
Ecolab (ECL): What's in the Cards this Earnings Season?
by Zacks Equity Research
St. Paul, MN-based Ecolab Inc. (ECL), a leading provider of water, hygiene and energy technologies and services, is expected to report fourth-quarter 2016 results on Feb 21.
DENTSPLY (XRAY) Q4 Earnings: Is Disappointment in Store?
by Zacks Equity Research
York, PA-based DENTSPLY Sirona Inc. (XRAY), a dental solutions company, is expected to report fourth-quarter 2016 results on Feb 10.
Will Q4 Earnings Hold a Surprise for DaVita (DVA) Stock?
by Zacks Equity Research
DaVita HealthCare Partners Inc. (DVA) is set to report fourth-quarter 2016 results after market close on Feb 9.
Why Earnings Season Could Be Great for DaVita (DVA)
by Zacks Equity Research
DaVita (DVA) looks like an exciting pick for investors as it is poised to beat at earnings season.
4 Healthcare Players Likey to Trump Q4 Earnings Estimates
by Zacks Equity Research
Trump's victory has sent waves across the Healthcare industry.
Cerner (CERN): What's in the Cards this Earnings Season?
by Zacks Equity Research
Cerner Corporation (CERN), a leading global provider of healthcare information technology solutions ("HCIT"), is set to report fourth-quarter 2016 results, after the closing bell on Feb 9.
Cardinal Health (CAH) Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Cardinal Health (CAH), a global player in the healthcare services and products space, is set to report second-quarter fiscal 2017 results on Feb 7, before the bell.
Pacific Biosciences (PACB): What Awaits in Q4 Earnings?
by Zacks Equity Research
Pacific Biosciences of California Inc. (PACB) is scheduled to report fourth-quarter 2016 results on Feb 1, 2017.
Varian Medical (VAR) Q1 Earnings: Is a Surprise in Store?
by Zacks Equity Research
Varian Medical Systems Inc. (VAR) is set to report results for the first quarter of fiscal 2017 on Jan 25, after the closing bell.
Is Earnings Beat Likely for Intuitive Surgical (ISRG) in Q4?
by Zacks Equity Research
We expect Intuitive Surgical Inc (ISRG) to beat earnings expectations when it reports fourth-quarter 2016 and full-year results on Jan 24.
Stryker (SYK): Can It Post a Beat this Earnings Season?
by Zacks Equity Research
Delving deeper into the fundamentals of Stryker Corporation (SYK), we expect the stock to beat earnings estimates this quarter.
DaVita Ties Up With WellHealth, Expands in Southern Nevada
by Zacks Equity Research
DaVita HealthCare Partners Inc. (DVA), a leading provider of dialysis services, announced that HealthCare Partners Nevada, a unit within its medical group, has acquired WellHealth Quality Care.
DaVita Ties Up With Inspira Health, Expands in South Jersey
by Zacks Equity Research
DaVita HealthCare Partners Inc. (DVA), a leading provider of dialysis services in the U.S., announced a joint venture with Inspira Health Network to expand dialysis services at the Bridgeton, Millville and Vineland centers of South Jersey.
Bear of the Day: DaVita HealthCare Partners (DVA)
by Kevin Cook
Shifting winds in Medicare and ACA exchanges clipped shares 18% in August. Are the lows in on this upgrade?
Bear of the Day: DaVita HealthCare Partners (DVA)
by Kevin Cook
Analysts saw this one coming and pushed the Zacks Rank down before a 13% drop since earnings